Detalles de la búsqueda
1.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica
; 108(8): 2091-2100, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36632738
2.
Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patients.
Hematol Oncol
; 41(3): 335-342, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36533316
3.
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy.
Hematol Oncol
; 38(4): 501-508, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32602970
4.
Role of chemotherapy in the treatment of chronic lymphocytic leukemia in the era of targeted therapies in Italy. A Campus CLL network report.
Hematol Oncol
; 41(1): 201-204, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35849302
5.
Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma.
Radiol Med
; 122(8): 623-632, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28421406
6.
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.
Hematol Oncol
; 39(4): 570-574, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34258787
7.
Richter's Syndrome of the Central Nervous System.
Can J Neurol Sci
; 48(6): 889-892, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33397524
8.
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study.
Am J Hematol
; 89(4): 355-62, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24273190
9.
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies.
Leuk Lymphoma
; 65(4): 460-471, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38164812
10.
Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin's Lymphomas.
Mediterr J Hematol Infect Dis
; 13(1): e2021018, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33747399
11.
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.
J Clin Med
; 10(6)2021 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33799685
12.
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study.
Cancers (Basel)
; 14(1)2021 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35008372
13.
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial.
J Hematol Oncol
; 12(1): 4, 2019 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30626425
14.
Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms.
Oncoimmunology
; 7(4): e1341032, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29632712
15.
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.
J Clin Oncol
; 36(5): 454-462, 2018 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29360414
16.
Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation.
Clin Lymphoma Myeloma Leuk
; 17(1): 14-22, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27727134
17.
Lentiviral transduction of primary myeloma cells with CD80 and CD154 generates antimyeloma effector T cells.
Hum Gene Ther
; 16(4): 445-56, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15871676
18.
Rate of primary refractory disease in B and T-cell non-Hodgkin's lymphoma: correlation with long-term survival.
PLoS One
; 9(9): e106745, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25255081
19.
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.
J Clin Oncol
; 32(7): 634-40, 2014 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24449241
20.
Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy.
Leuk Lymphoma
; 54(6): 1183-7, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23035692